Invention Grant
- Patent Title: Antibodies that bind to OX40 and their uses
-
Application No.: US16298289Application Date: 2019-03-11
-
Publication No.: US11407839B2Publication Date: 2022-08-09
- Inventor: Antoine Attinger , Stanislas Blein , Jonathan Albert Back , Rami Lissilaa , Samuel Hou
- Applicant: Ichnos Sciences SA
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: Ichnos Sciences SA
- Current Assignee: Ichnos Sciences SA
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K39/00 ; A61K45/06
Abstract:
The present invention relates to antagonist antibodies or fragments thereof that bind to human OX40. More specifically, the present invention relates to an antagonist antibody or fragment thereof that binds to human OX40 comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 1, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 2, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 3; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 4, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 5 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 6.
Public/Granted literature
- US20200071409A1 Antibodies That Bind To OX40 and Their Uses Public/Granted day:2020-03-05
Information query
